Hony offloads CSPC stake in $1.26b sale

The Chinese private equity firm takes advantage of scorching Hong Kong capital markets to divest holding in mainland pharma firm.

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition

CONFERENCES